Disrupting Specific Protein May Be Effective Multiple Myeloma Treatment Strategy
Researchers at Buffalo, New York-based Roswell Park Cancer Institute…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreResearchers at Buffalo, New York-based Roswell Park Cancer Institute…
Researchers at The University of Texas MD Anderson…
Takeda Pharmaceutical has published promising data from the TOURMALINE-MM1…
The International Myeloma Foundation (IMF) has announced new funding for the…
A preliminary clinical study at Johns Hopkins Kimmel…
The diagnosis and management of myeloma in the very elderly is…